Patents by Inventor Samuel Weisbrod

Samuel Weisbrod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protecting group comprising a purification tag
    Patent number: 10040850
    Abstract: The present invention relates to compounds comprising a protecting group moiety-tag moiety conjugate, a method of purification and monoconjugates obtained from such method of purification.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: August 7, 2018
    Assignee: Ascendis Pharma A/S
    Inventors: Harald Rau, Nicola Bisek, Thomas Knappe, Romy Reimann, Sebastian Stark, Samuel Weisbrod
  • PREVENTION AND TREATMENT OF OCULAR CONDITIONS
    Publication number: 20170112939
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrogel-linked prodrug for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
    Type: Application
    Filed: January 6, 2017
    Publication date: April 27, 2017
    Applicant: Ascendis Pharma Ophthamology Division A/S
    Inventors: Thomas KNAPPE, Burkhardt Laufer, Harald Rau, Kennett Sprogøe, Tobias Voight, Samuel Weisbrod
  • PROTECTING GROUP COMPRISING A PURIFICATION TAG
    Publication number: 20160257739
    Abstract: The present invention relates to compounds comprising a protecting group moiety-tag moiety conjugate, a method of purification and monoconjugates obtained from such method of purification.
    Type: Application
    Filed: October 7, 2014
    Publication date: September 8, 2016
    Applicant: Ascendis Pharma A/S
    Inventors: Harald Rau, Nicola Bisek, Thomas Knappe, Romy Reimann, Sebastian Stark, Samuel Weisbrod
  • VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions
    Publication number: 20150297740
    Abstract: The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a VEGF neutralizing prodrug, which comprises a VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions.
    Type: Application
    Filed: October 8, 2013
    Publication date: October 22, 2015
    Inventors: Harald RAU, Thomas KNAPPE, Burkhardt Laufer, Romy REIMANN, Samuel WEISBROD, Kennett SPROGØE, Nicola BISEK, Sebastian STARK, Tobias VOIGT
  • PREVENTION AND TREATMENT OF OCULAR CONDITIONS
    Publication number: 20150010634
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrogel-linked prodrug for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
    Type: Application
    Filed: October 11, 2012
    Publication date: January 8, 2015
    Applicant: Ascendis Pharma Ophthamology Division A/S
    Inventors: Thomas Knappe, Burkhardt Laufer, Harald Rau, Kennett Sprogøe, Tobias Voigt, Samuel Weisbrod